Alimera Sciences, Inc.

Sep 17, 2018

Alimera Sciences Announces Nine Clinical Presentations and a Sponsored Symposium at 18th EURETINA Congress

Sep 13, 2018

Alimera Sciences Announces Three Podium Presentations for ILUVIEN® to be Presented at 2018 Retina Society's Annual Meeting

Sep 04, 2018

Alimera Sciences Announces Exchange of Series B Preferred Stock for Newly Issued Series C Preferred Stock

Aug 29, 2018

Alimera Sciences to Present at the 20th Annual HC Wainwright Global Investment Conference

Aug 28, 2018

Alimera Sciences to Present at the Annual B. Riley Healthcare Conference

Jul 30, 2018

Alimera Sciences Reports Second Quarter 2018 Results

Jul 18, 2018

Alimera Sciences to Report Second Quarter 2018 Results July 30, 2018

Jul 11, 2018

Alimera Sciences Announces 8 ILUVIEN® Presentations At The 2018 American Society Of Retina Specialists Annual Meeting

Jun 21, 2018

Alimera Sciences Appoints Mary T. Szela to its Board of Directors

Jun 11, 2018

The UK National Institute For Health And Care Excellence To Undertake A Partial Review Of The ILUVIEN Reimbursement Guidance Allowing Broader Availability

Jun 04, 2018

Alimera Sciences Terminates At-the-Market Offering Agreement

May 31, 2018

Alimera Sciences Announces the Reimbursement of ILUVIEN® in Spain

May 22, 2018

Alimera Sciences to Present at the 8th Annual LD Micro Invitational Conference